Loading clinical trials...
Loading clinical trials...
A Single Arm, Multi-center Phase 2 Trial of mFOLFOX6 + Trastuzumab + Avelumab in First-line, Metastatic, HER2-amplified Gastric and Esophageal Adenocarcinomas
Conditions
Interventions
Oxaliplatin
Leucovorin
+3 more
Locations
7
United States
City of Hope
Duarte, California, United States
Winship Cancer Insititute of Emory University
Atlanta, Georgia, United States
Northwestern University Feinberg School of Medicine
Chicago, Illinois, United States
University of Iowa Hospital and Clinics
Iowa City, Iowa, United States
Atlantic Health System
Morristown, New Jersey, United States
Roswell Park Cancer Institute
Buffalo, New York, United States
Start Date
January 24, 2019
Primary Completion Date
September 11, 2020
Completion Date
August 30, 2022
Last Updated
December 19, 2023
NCT06340711
NCT06831032
NCT07213804
NCT07478289
NCT04668872
NCT06901531
Lead Sponsor
Ashwin Somasundaram
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions